All Infection Prevention & Control articles – Page 2
-
NewsResearchers track the mutations that allow HIV-1 to escape broadly neutralizing antibodies
Scientists have established the most comprehensive view to date of how HIV-1 can escape broadly neutralizing antibodies. They have discovered viral mutations that make HIV-1 strains resistant to two bNAbs, 3BNC117 and 10-1074.
-
NewsUKHSA update on the hantavirus cruise ship outbreak
The UK Government has announced it has worked with international partners to ensure the safe return of all remaining British nationals on board the MV Hondius, with passengers now safely transferred to Arrowe Park Hospital.
-
NewsPregnant women’s mental images are directly linked to vaccine hesitancy and uptake
When pregnant women think about vaccinations, many experience vivid mental images – such as a sick baby in hospital – that have a direct link to their opinion of the vaccine and whether they ultimately have it, new research has shown.
-
NewsInvisible smart bug fights gum disease
Current treatments for periodontitis often fail because they cannot simultaneously eliminate stubborn bacterial biofilms and calm the runaway inflammation that follows. Now researchers have engineered a living bacterium that does both, in the right order.
-
NewsExpanded tuberculosis screening does not speed up treatment initiation or improve survival in hospitalized patients with HIV
According to the EXULTANT trial, adding molecular tests on sputum, urine and stool samples does not appear to outperform the standard WHO-recommended diagnostic approach.
-
NewsMouse study suggests high-fat diets during pregnancy worsen severe GI illness in preterm babies
A new mouse study suggests a link between a high-fat prenatal diet and induction of potentially deadly symptoms of necrotizing enterocolitis (NEC) in premature babies.
-
NewsScientists take crucial step in developing world’s first measles treatment
Scientists have characterized human antibodies capable of neutralizing measles virus. These antibodies bind to key sites on measles virus and prevent the virus from entering host cells.
-
NewsScientists discover how gut bacteria toxin invades colon cells to trigger cancer
A common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. Researchers have now shown that the B. fragilis toxin BFT must first bind host receptor claudin-4 before it can cause damage.
-
News‘Atomic snapshots’ of proofreading enzyme could lead to better COVID-19 drugs
A research team used images generated by a cryogenic electron microscope (cryo-EM) to observe the interplay between SARS-CoV-2 proofreading enzyme exoribonuclease (ExoN) and RNA incorporated with antivirals such as remdesivir, sofosbuvir and bemnifosbuvir.
-
NewsNeedle-free flu vaccine aims to boost children’s immunity
A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems, aiming to boost future protection and lower vaccine hesitancy rates.
-
NewsSeasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada
An interim analysis estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine’s target strain.
-
NewsTuberculosis risk: promising approaches for screening and prediction
It is currently difficult to detect TB in its early stages, or predict who will go on to have TB, and therefore preventive treatment is not widely used. Researchers assessed whether a blood-based 3-gene host-response test can detect active tuberculosis and help predict future disease.
-
NewsLong-term dynamic virological response patterns and clinical outcomes in hepatitis B virus-related cirrhosis
The long-term clinical outcomes of patients with hepatitis B virus (HBV)-related cirrhosis receiving nucleos(t)ide analog (NA) therapy according to virological response patterns remain inadequately defined. A new study aimed to investigate the association between virological response patterns and clinical outcomes.
-
NewsResearchers find diagnostic delays are common for US pediatric patients with malaria
Researchers found that more than one in four pediatric patients treated for malaria in the United States had a delay in their initial diagnosis, increasing the risk of more severe infection.
-
NewsScientists use ultrasound to destroy influenza A and COVID-19 viruses without damaging human cells
Researchers have discovered that high-frequency ultrasound waves similar to those used in medical exams can eliminate viruses such as SARS-CoV-2 and H1N1 without damaging human cells. Acoustic resonance causes structural changes in viral particles until they rupture and become inactivated.
-
NewsNew kind of CRISPR could treat viral infection and cancer by shredding sick cells’ DNA
A new technology uses a relative of the CRISPR-Cas9 gene editing system to kill target cells. When activated by a specific, programmable genetic target, the Cas12a2 protein rips a cell’s genome apart. Researchers programmed Cas12a2 to kill virus-infected cells or cancer cells while leaving healthy cells untouched.
-
NewsDNA analyses uncover what is hiding under the cap plaguing the white button mushroom industry
Researchers have uncovered that bacterial blotch is not caused by a single disease-causing bacteria or pathogen as originally learned, but by a complex of pathogenic bacterial species that thrive in the indoor controlled, humid environments where they are grown.
-
NewsScientists discover how HIV hijacks a cellular ‘gateway’ to infect resting immune cells
New research reveals that when HIV spreads directly between T-cells it triggers a molecular signalling chain that temporarily ‘unlocks’ the nuclear pore complex, allowing the HIV virus and capsid to enter and integrate into the host’s DNA.
-
NewsResearchers identify potential new route for antimalarial drug design
Researchers have uncovered a promising new potential target for drug discovery. The team focused on an enzyme called aminopeptidase P (PfAPP) from Plasmodium falciparum, the parasite responsible for the most severe form of malaria in humans.
-
NewsPolymer ‘bristles’ could help repel proteins — and germs — from surfaces in medical settings
A non-toxic coating made of polydimethylsiloxane prevents proteins from sticking to surfaces — potentially offering a new tool in the fight against hospital-acquired infections.